Year: 2020

Some governing bodies have temporarily changed certain regulations so that healthcare providers can do as much as possible to deliver high-quality care virtually. Some areas of care become more challenging in a virtual environment, but with the right support tools in place, these challenges can be mitigated. In this blog, you’ll learn how these changes affect how online doctors can prescribe controlled substances. 

In today’s article, our Chief Scientific Officer, Prof. Martin Dawes will discuss the role of pharmacogenetics in treating depression. You’ll also learn about a solution that enables the use of evidence-based pharmacogenetics at the point of care.

In this interview with our Algorithm Team Manager, Andrea Paterson, she talks about the exciting updates on our TreatGx software, and how to use it to select the best medication options for patients with depression. 

Do you sometimes feel down, unengaged, or depressed?  You are not alone! In North America, the impact of mental illnesses is huge and intractable. One in five U.S. adults experiences mental illness each year. Similarly, 1 in 5 Canadians experiences a…

If you work in healthcare, you probably heard of the word “Interoperability” at least once, or perhaps too many times. Whether you heard it from a co-worker or your favorite healthcare influencer, health data interoperability is becoming more important than ever. But does it live up to the hype?